Resistance rates for both clarithromycin and metronidazole appear to reflect the annual consumption of these agents. The high rate of clarithromycin resistance in Japan suggests that the effectiveness of clarithromycin-based therapies may be compromised in the near future.
Pt-based
nanostructured electrocatalysts supported on carbon black
have been widely studied for the oxygen reduction reaction (ORR),
which occurs at the cathode in polymer electrolyte fuel cells. Because
sluggish ORR kinetics are known to govern the cell performance, there
is a need to develop highly active and durable electrocatalysts. The
ORR activity of Pt-based electrocatalysts can be improved by controlling
their morphology and alloying Pt with transition metals such as Ni.
Improving the catalyst durability remains challenging and there is
a lack of catalyst design concepts and synthetic strategies. We report
the enhancement of the ORR activity and durability of a nanostructured
Pt–Ni electrocatalyst by strong metal/support interactions
with a nitrogen-doped carbon (NC) support. Pt–Ni rhombic dodecahedral
nanoframes (NFs) were immobilized on the NC support and showed higher
ORR electrocatalytic activity and durability in acidic media than
that supported on a nondoped carbon black. Durability tests demonstrated
that NF/NC showed almost no activity loss even after 50 000
potential cycles under catalytic conditions, and the Ni dissolution
from the NFs was suppressed at the NC support, as confirmed by energy
dispersive X-ray spectroscopy analysis. Physicochemical measurements
including surface-enhanced infrared absorption spectroscopy of surface-adsorbed
CO revealed that the strong metal/support interactions of the NF with
the NC support caused the downshift of the d-band center position
of the surface Pt. Our findings demonstrate that tuning the electronic
structure of nanostructured Pt alloy electrocatalysts via the strong
metal/support interactions with heteroatom-doped carbon supports will
allow the development of highly active and robust electrocatalysts.
The
light-harvesting 1 reaction center (LH1-RC) complex in the purple
sulfur bacterium Thiorhodovibrio (Trv.) strain 970 cells exhibits its LH1 Q
y
transition at 973 nm, the lowest-energy Q
y
absorption among purple bacteria
containing bacteriochlorophyll a (BChl a). Here we characterize the origin of this extremely red-shifted Q
y
transition. Growth of Trv. strain 970 did not occur in cultures free of Ca2+, and elemental analysis of Ca2+-grown cells confirmed
that purified Trv. strain 970 LH1-RC complexes contained
Ca2+. The LH1 Q
y
band of Trv. strain 970 was blue-shifted
from 959 to 875 nm upon Ca2+ depletion, but the original
spectral properties were restored upon Ca2+ reconstitution,
which also occurs with the thermophilic purple bacterium Thermochromatium (Tch.) tepidum. The amino acid
sequences of the LH1 α- and β-polypeptides from Trv. strain 970 closely resemble those of Tch. tepidum; however, Ca2+ binding in the Trv. strain
970 LH1-RC occurred more selectively than in Tch. tepidum LH1-RC and with a reduced affinity. Ultraviolet resonance Raman
analysis indicated that the number of hydrogen-bonding interactions
between BChl a and LH1 proteins of Trv. strain 970 was significantly greater than for Tch. tepidum and that Ca2+ was indispensable for maintaining these
bonds. Furthermore, perfusion-induced Fourier transform infrared analyses
detected Ca2+-induced conformational changes in the binding
site closely related to the unique spectral properties of Trv. strain 970. Collectively, our results reveal an ecological
strategy employed by Trv. strain 970 of integrating
Ca2+ into its LH1-RC complex to extend its light-harvesting
capacity to regions of the near-infrared spectrum unused by other
purple bacteria.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.